Figures & data
Notes: Adherence rates determined through biochemical testing in 256 patients. Minimally adapted from Atheroscler Suppl, Gupta P, Mohamed AA, Patel P, et al, 34, High rates of non-adherence to antidiabetic, antihypertensive and lipid lowering treatment in patients with type 2 diabetes revealed liquid chromatography-tandem mass spectrometry (lc-ms/ms) urine analysis, e2, Copyright 2018,Citation20 with permission from Elsevier.
Abbreviations: ACE/ARBs, angiotensin-converting enzyme inhibitors/angiotensin II receptor antagonists; AD, antidiabetics; AH, antihypertensives; BB, beta blockers; CCB, calcium channel blockers; DI, diuretics.
Abbreviations: ACE/ARBs, angiotensin-converting enzyme inhibitors/angiotensin II receptor antagonists; AD, antidiabetics; AH, antihypertensives; BB, beta blockers; CCB, calcium channel blockers; DI, diuretics.
Notes: Cohort sizes for good, intermediate, and poor adherences were N=12,647, N=10,846, and N=11,223, respectively. Data were adjusted using common clinical factors and patient identifiers, with bars indicating 95% CI. Data were adapted from Kim S, Shin DW, Yun JM, et al. Medication adherence and the risk of cardiovascular mortality and hospitalization among patients with newly prescribed antihypertensive medications. Hypertension. 2016;67:506–512.Citation44